Reclaiming Congress’s Constitutional Mandate in Trade Resolution
Sponsored By: Representative Griffith
Introduced
Summary
Shift U.S. trade authority from the executive branch to Congress. This concurrent resolution would create a Joint Ad Hoc Committee to design a plan to move the Office of the U.S. Trade Representative's functions into the legislative branch and would establish a Congressional Advisory Board to advise that effort.
Show full summary
- A 14-member Joint Ad Hoc Committee would be formed from House and Senate trade-related committees. The committee could subpoena witnesses, hire experts, and must submit a transfer plan within 16 months after all members are appointed.
- The U.S. Trade Representative and other executive agencies would be required to provide information and assistance to the committee and advisory board. The bill conditions any transfer on the committee’s plan and sets a latest possible transfer point tied to a four-year period or July 1, 2028.
- A 21-member Congressional Advisory Board would include appointees from congressional leaders and the USTR and representatives of labor, industry, agriculture, small business, environmental groups, and consumers. Members serve without pay and non-Washington residents may receive travel expenses.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Plan to move trade policy to Congress
If adopted by both chambers, this resolution would create a 14‑member Joint Ad Hoc Committee to plan moving U.S. trade duties from the U.S. Trade Representative to Congress. Nine House members and five Senators would serve; leaders would appoint them and name a Chair and Vice Chair. The committee could meet 90 days after adoption, call witnesses, require documents, and hire experts using existing staff when possible. Witnesses asked to appear would have travel costs reimbursed. The committee must send its plan to Congress within 16 months after all members are appointed. The transfer of USTR functions would then occur four years after that report, or on July 1, 2028, whichever is later. Its costs would be paid from House accounts and the Senate contingent fund, and it would end one year after it files its report. A 21‑member Advisory Board would be appointed within 60 days, including the USTR or a designee; members would be unpaid, with travel and per diem for non‑local members, and the board could not hire staff but could request help from the Joint Committee. The USTR and other executive‑branch offices would be required to provide the information and help the committee and board reasonably need.
Sponsors & CoSponsors
Sponsor
Griffith
VA • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govRelated Bills
HR3877 — Washington, D.C. Residents Voting Act
Return most of the District of Columbia to Maryland. The bill would cede the territory that once constituted D.C. back to Maryland while carving out and preserving a smaller, defined Federal District that holds the Mall, the White House, the Capitol, the Supreme Court, and other major federal buildings. - Residents and households in the ceded area would become subject to Maryland law and no longer have a separate D.C. municipal status. Certain D.C. programs would continue to apply to eligible residents in the ceded territory, including college access and scholarship provisions. - Federal and justice-sector workers get targeted transition protections. The bill keeps federal benefit treatment for many employees who served before retrocession or who transfer to Maryland roles, including judges, Public Defender Service staff, parole and supervision personnel, and certain court employees. - Federal property, boundaries, and representation are reconfigured. The act defines an 84-point Federal District boundary and requires a metes-and-bounds survey within 180 days. It preserves exclusive federal ownership and jurisdiction over reserved lands. The D.C. Delegate post is repealed and the former Delegate becomes a temporary Maryland House member as one additional seat until the first post-retrocession reapportionment. Retrocession would take effect only after Maryland accepts it and the President issues a proclamation.
HR3843 — Baseload Reliability Protection Act
Stops certain baseload power plants from retiring or switching fuel in regions the grid monitor rates as at elevated or high risk of electricity shortfalls, while creating a fast exemption process and a DOE grant and loan backstop. This bill targets dispatchable units of at least 25 megawatts that feed the bulk‑power system and are not primarily intermittent renewables. - Families and consumers: Keeps at‑risk power capacity online so regions served by an RTO or ISO face fewer near‑term supply shortfalls and outages. - Plant owners and operators: Would bar retirement or fuel conversion for covered units but lets owners petition for exemptions within 90 days and seeks final agency action quickly, with a 180‑day special timeline for claims based on unprofitability. - Grid planners and federal agencies: Requires the Electric Reliability Organization to set standardized risk criteria and a probabilistic method for long‑term reliability assessments, and directs DOE to offer grants or loans from specified unobligated funds to support continued operation or replacements. Would authorize DOE to use unobligated IIJA and related funds for grants or loans to keep covered units operating, and any loan interest would be paid into the Treasury.
HR1227 — Alternatives to PAIN Act
Lowering cost and access barriers for qualifying non-opioid pain management drugs under Medicare Part D. This bill would make certain non-opioid pain drugs cheaper and easier to get for Medicare enrollees. - Medicare Part D enrollees would pay less out of pocket because qualifying non-opioid pain drugs would not be subject to the Part D deductible and must be placed on the lowest cost-sharing tier when calculating maximum co-insurance or other cost-sharing. These changes apply for plan years beginning on or after January 1, 2026. - Low-income Medicare enrollees who receive Part D subsidies would get the same deductible waiver and lowest-tier placement for qualifying drugs when calculating their maximum cost-sharing, for plan years beginning on or after January 1, 2026. - Prescription drug plans and Medicare Advantage prescription drug plans would be barred from imposing step therapy or prior authorization for qualifying non-opioid pain drugs, reducing administrative hurdles for patients and providers beginning in 2026. - A qualifying non-opioid pain drug must have an FDA-approved indication for acute or postoperative pain, not act on opioid receptors, lack a therapeutically equivalent U.S. product, and have a monthly wholesale acquisition cost below a specialty-tier cost threshold that the Secretary may set and update.
HR278 — BROADBAND Leadership Act
Limits state and local barriers to siting telecommunications facilities. This bill would bar states and localities from discriminating against or effectively blocking the placement, construction, or modification of facilities used to provide interstate or intrastate telecommunications service. - State and local governments would have tighter limits on how they regulate siting. They could still manage rights‑of‑way and set non‑discriminatory rules for public safety and universal service. They may charge reasonable, cost‑based fees that are technology‑neutral and publicly disclosed. - Providers would face firm timelines for approvals: 90 days for requests involving existing support infrastructure and 150 days for other actions. If an authority misses a deadline the request would be deemed approved after the requester sends a written notice. - The bill would require written denials supported by substantial evidence and public release. It would allow expedited court review and let the Federal Communications Commission seek to preempt violating state or local rules, with a 120‑day decision window.
HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.
HR7008 — Stop Insider Trading Act
This bill would create new limits and public disclosure rules to prevent insider trading by Members of Congress. It would ban purchases of specified public securities and synthetic interests by Members, their spouses, and dependent children and set rules for sales and enforcement.
Previous / Next Bills
Take It Personal
Get Your Personalized Policy View
Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.
Already have an account? Sign in